Brief: Lava Therapeutics Provides Business Update And Reports First Quarter Financial Results
May 17 (Reuters) - LAVA Therapeutics NV LVTX.O :
* LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER
FINANCIAL
RESULTS
* LAVA THERAPEUTICS NV- CASH AND INVESTMENTS OF $124.2 MILLION AS OF MARCH
31,
2022
* LAVA THERAPEUTICS NV - QTRLY LOSS PER SHARE $0.41
Source text for Eikon: ID:nGNX6X2pPQ
Further company coverage: LVTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LAVA Therapeutics NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:29 PM
Brief: Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM